Nascent Biotech Inc.: Nascent Biotech Receives $750k Milestone Payment from BioRay Pharmaceutical
Milestone Payment is the Second of Four in $5M Pritumumab Licensing DealVERO BEACH, FL / ACCESSWIRE / February 23, 2022 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company")